ARTIS Ventures is a venture capital firm that invests in category defining companies in TechBio, the intersection of technology and biology.
ARTIS Ventures is a financial services firm that finances early-to-late stage venture investments. The team supports its portfolio companies through their entire life-cycle, from initial venture investment to public offering and beyond.It was founded in 2001 and headquartered in San Francisco, California.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 7, 2022
Second Front Systems
|
Series A | $32M | Information Services | — |
Apr 19, 2022
Tessera Therapeutics
|
Series C | $300M | Biopharma | — |
Dec 7, 2021
Freenome
|
Series D | $300M | Biotechnology | — |
Nov 10, 2021
Rad AI
|
Series A | $25M | Artificial Intelligence | Yes |
Sep 30, 2021
Activ Surgical
|
Series B | $45M | Artificial Intelligence | — |